Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides

Exclusion Criteria

• •Newly diagnosed mycosis fungoides with no prior therapy
• •A prior history of treatment with topical NM within the past 2 years or topical carmustine (BCNU)
• •Use of topical or systemic therapies for MF within four (4) weeks of entry in the study
• •Patients with a diagnosis of stage IIB-IV MF
• •Serious known concurrent medical illness or infection, which could potentially present a safety risk and/or prevent compliance with the requirements of the treatment program
• •Pregnant or nursing females, or males and females of childbearing potential, not using an effective means of contraception
• •Patients who have had radiation therapy within one year of study start
• •Patients who have a history of a higher T score than T2 or a higher N score than N1
• •Patients who do not agree to do all labs at one site